Comment Closes On
|
|
Committee
|
CH/194 |
Document Type
|
Draft |
ISBN
|
|
Pages
|
|
Published
|
|
Publisher
|
British Standards Institution
|
Status
|
Superseded |
Superseded By
|
|
ISO 10993-16:2017
|
Biological evaluation of medical devices — Part 16: Toxicokinetic study design for degradation products and leachables |
ISO 13781:2017
|
Implants for surgery — Homopolymers, copolymers and blends on poly(lactide) — In vitro degradation testing |
ISO 10993-12:2012
|
Biological evaluation of medical devices Part 12: Sample preparation and reference materials |
ISO 10993-17:2002
|
Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substances |
ISO 10993-1:2009
|
Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process |
ISO 10993-9:2009
|
Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products |
ISO 3696:1987
|
Water for analytical laboratory use — Specification and test methods |
ISO 14971:2007
|
Medical devices Application of risk management to medical devices |
ISO 10993-6:2016
|
Biological evaluation of medical devices Part 6: Tests for local effects after implantation |
Unfortunately, this product is not available for purchase in your region.
-
Access your standards online with a subscription
Features
- Simple online access to standards, technical information and regulations
- Critical updates of standards and customisable alerts and notifications
- Multi - user online standards collection: secure, flexibile and cost effective